Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2016-08-09

Clinical Trial Update: Observatory of the Prescription of Erythropoietin as Treatment of Anemia Induced by Chemotherapy or Allograft Conditioning Among the Patients With a Haematological Malignancy

View source ↗

Summary

An observational clinical trial update examining how erythropoietin is prescribed to treat chemotherapy- or conditioning-induced anemia in patients with hematol…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Erythropoietin (erythropoietin)

Snippet

Sponsor: Hospices Civils de Lyon | Conditions: Anemia, Acute Myeloid Leukemia | Status: UNKNOWN